Aktis Oncology Common stock Share Price AKTS
$18.61
Last updated on
Check the interactive Aktis Oncology Common stock Stock chart to analyse performance
Aktis Oncology Key Stats
Check Aktis Oncology Common stock key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Aktis Oncology Common stock Stock including INR - Dollar returns
The Aktis Oncology Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Aktis Oncology Common stock investment value today
Current value as on today
Returns
(0%)
Returns from Aktis Oncology Common stock Stock
(0%)
Dollar Impact
(0%)
Indian investors sentiment towards Aktis Oncology Common stock Stock
Global Institutional Holdings in Aktis Oncology
Name
Holdings %
Vanguard Group Inc
2.09%
Taylor Frigon Capital Management LLC
1.66%
Silverback Aset Management LLC
1.64%
Citadel Advisors Llc
1.36%
RIMA MANAGEMENT, LLC
0.97%
BlackRock Inc
0.78%
Analyst Recommendation on Aktis Oncology Common stock Stock
Buy
72%Buy
27%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Aktis Oncology Common stock(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Aktis Oncology Common stock Share Price Target
What analysts predicted
Upside of 74.1%
Target:
$32.40
Current:
$18.61
Aktis Oncology Common stock share price target is $32.40, a slight Upside of 74.1% compared to current price of $18.61 as per analysts' prediction.
Aktis Oncology Common stock Stock Insights
Price Movement
In the last 6 months, AKTS stock has moved up by 52453.8%Increasing Revenue
Revenue is up for the last 3 quarters, 933.0K → 3.22M (in $), with an average increase of 46.1% per quarterDecreasing Net Profit
Netprofit is down for the last 4 quarters, -6.42M → -18.32M (in $), with an average decrease of 44.8% per quarter
Aktis Oncology Common stock Technicals Summary
Sell
Neutral
Buy
Aktis Oncology Common stock is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Aktis Oncology Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -6.14% | -12.72% | -12.72% | 574.14% | 109.76% |
 | -6.83% | -3.73% | 17.05% | -7.09% | 36.06% |
 | -0.39% | 106.38% | 264.79% | 445.75% | 360.95% |
 | -0.51% | 0.33% | -0.84% | 28.53% | 101.72% |
 | -7.71% | -37.92% | -1.67% | 48.65% | 104.84% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.35 | -0.29 | -0.16 | NA | 9.16 |
| 17.39 | 17.39 | 1.46 | 46.5 | 0.15 | 0.06 | 0.01 | 304.65 |
| NA | NA | NA | -7.96 | -0.77 | -0.38 | NA | 7.49 |
| 26.89 | 26.89 | 1.62 | 19.17 | 0.24 | 0.12 | NA | 76.18 |
| 73.55 | 73.55 | 0.5 | 9.33 | 0.9 | 0.1 | NA | 8.06 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $1.1B | 109.76% | NA | 0.0% |
| Buy | $74.7B | 36.06% | 17.39 | 29.65% |
| Buy | $31.8B | 360.95% | NA | 0.0% |
| Buy | $115.0B | 101.72% | 26.89 | 35.51% |
| Buy | $39.2B | 104.84% | 73.55 | 12.55% |
About Aktis Oncology
Key Management of Aktis Oncology
Important FAQs about investing in AKTS Stock from India :
What is Aktis Oncology Common stock share price today?
Aktis Oncology Common stock share price today is $18.61 as on at the close of the market. Aktis Oncology Common stock share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Aktis Oncology Common stock share?
Aktis Oncology Common stock share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Aktis Oncology Common stock stock price today i.e. is closed at $18.61, lower by 0% versus the 52 week high.
How to invest in Aktis Oncology Common stock Stock (AKTS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aktis Oncology Common stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aktis Oncology Common stock Shares that will get you 0.0806 shares as per Aktis Oncology Common stock share price of $18.61 per share as on May 19, 2026 at 10:37 pm IST.
What is the minimum amount required to buy Aktis Oncology Common stock Stock (AKTS) from India?
Indian investors can start investing in Aktis Oncology Common stock (AKTS) shares with as little as ₹96.2725 or $1 (as of May 19, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹962.72 in Aktis Oncology Common stock stock (as per the Rupee-Dollar exchange rate as on May 19, 2026).
Based on Aktis Oncology Common stock share’s latest price of $18.61 as on May 19, 2026 at 10:37 pm IST, you will get 0.5373 shares of Aktis Oncology Common stock. Learn more about
fractional shares .
What are the returns that Aktis Oncology Common stock has given to Indian investors in the last 5 years?
Aktis Oncology Common stock stock has given 109.76% share price returns and 31.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
SpyGlass Pharma, Inc.$22.24
-4.18%
- Damora Therapeutics Inc
$24.90
+1.22%
- Canton Strategic Holdings Inc
$3.26
-9.94%
- ENvue Medical Inc
$1.01
-7.34%
Filana Therapeutics Inc$1.19
+0.85%
- ROCKET DOCTOR AI INC COM
$0.45
+7.14%
- REGENTIS BIOMATERIALS LTD/IS
$1.93
-10.23%
Valion Bio Inc$0.86
-2.27%
- Generate Biomedicines
$13.01
-18.69%